Hematology TimesIsatuximab Quadruplet Approval Could Change the Landscape for Treating MyelomaOctober 7, 2024Multiple MyelomaTransplantation
Hematology NewsExtended virus shedding after COVID-19 in some patients with cancerDecember 10, 2020Patient & Survivor CareCOVID-19 UpdatesLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantMultiple MyelomaMyelodysplastic Syndrome
Hematology NewsPatient-focused precautions, testing help blunt pandemic effects on heme-onc unitMay 26, 2020COVID-19 UpdatesPractice ManagementBreast CancerGastroenterologyGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, Transplantation
Hematology NewsREACH2: Ruxolitinib outperformed control treatment for refractory acute GVHDApril 22, 2020TransplantLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantation
Hematology NewsPhase 2 study shows regimen benefit with dasatinib in Ph+ALL therapyJanuary 22, 2020ALLTransplantation
Hematology NewsCAR T-cell therapy may worsen mental health in some patientsJanuary 21, 2020Cellular TherapyTransplantCLLTransplantationMixed TopicsLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Hematology NewsSeveral factors may drive recent improvements in allo-HCT outcomesJanuary 20, 2020TransplantationTransplantCellular TherapyPatient & Survivor Care
Hematology NewsPT-Cy bests conventional GVHD prophylaxisDecember 10, 2019TransplantationPatient & Survivor CareCellular Therapy
Hematology NewsMyeloma patients over age 70 can benefit from auto-HC transplantDecember 7, 2019TransplantationMultiple MyelomaTransplantLymphoma & Plasma Cell DisordersRare Diseases
Oncology PracticeCase-control study IDs several novel risk factors of post-HCT melanomaNovember 6, 2019MelanomaPatient & Survivor CareTransplantation
Hematology NewsFirst NCCN guideline on hematopoietic cell transplantation focuses on GVHDNovember 5, 2019TransplantationPatient & Survivor CareTransplant
Hematology NewsHematopoietic cell transplant offers realistic cure in secondary AMLOctober 23, 2019AMLTransplantTransplantationLeukemia, Myelodysplasia, Transplantation
Hematology NewsOngoing research aims to improve transplant outcomes in sickle cellSeptember 26, 2019AnemiaTransplantTransplantation
Hematology NewsSeveral factors may affect immune suppression discontinuation after HCTSeptember 26, 2019TransplantationTransplantLeukemia, Myelodysplasia, Transplantation
Hematology NewsASCT may cure follicular lymphoma for some rituximab-naive patientsSeptember 24, 2019Follicular LymphomaB Cell LymphomaTransplantationTransplantLymphoma & Plasma Cell Disorders
